170 related articles for article (PubMed ID: 33562511)
21. Nanoencapsulation Motivates the High Inhibitive Ability of Fucoxanthin on H
Wang C; Bai Y; Yin W; Qiu B; Jiang P; Dong X; Qi H
J Agric Food Chem; 2023 Apr; ():. PubMed ID: 37026562
[TBL] [Abstract][Full Text] [Related]
22. Nutraceutical characteristics of the brown seaweed carotenoid fucoxanthin.
Miyashita K; Beppu F; Hosokawa M; Liu X; Wang S
Arch Biochem Biophys; 2020 Jun; 686():108364. PubMed ID: 32315653
[TBL] [Abstract][Full Text] [Related]
23. Fabrication of betamethasone micro- and nanoparticles using supercritical antisolvent technology: In vitro drug release study and Caco-2 cell cytotoxicity evaluation.
Wang X; He S; Wang K; Wang X; Yan T; Yan T; Wang Z
Eur J Pharm Sci; 2023 Feb; 181():106341. PubMed ID: 36435356
[TBL] [Abstract][Full Text] [Related]
24. Induction of Apoptosis in Human Glioma Cells by Fucoxanthin via Triggering of ROS-Mediated Oxidative Damage and Regulation of MAPKs and PI3K-AKT Pathways.
Wu HL; Fu XY; Cao WQ; Xiang WZ; Hou YJ; Ma JK; Wang Y; Fan CD
J Agric Food Chem; 2019 Feb; 67(8):2212-2219. PubMed ID: 30688446
[TBL] [Abstract][Full Text] [Related]
25. The charge-transfer properties of the S2 state of fucoxanthin in solution and in fucoxanthin chlorophyll-a/c2 protein (FCP) based on stark spectroscopy and molecular-orbital theory.
Premvardhan L; Sandberg DJ; Fey H; Birge RR; Büchel C; van Grondelle R
J Phys Chem B; 2008 Sep; 112(37):11838-53. PubMed ID: 18722413
[TBL] [Abstract][Full Text] [Related]
26. Isolation and Purification of Fucoxanthin from Brown Seaweed
Ye Y; Sun J; Wang L; Zhu J; Cui W; Hou H; Zhang J; Zhou C; Yan X
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206231
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, tissue distribution, and metabolites of a polyvinylpyrrolidone-coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MS.
Ding XY; Hong CJ; Liu Y; Gu ZL; Xing KL; Zhu AJ; Chen WL; Shi LS; Zhang XN; Zhang Q
Int J Nanomedicine; 2012; 7():1723-35. PubMed ID: 22619523
[TBL] [Abstract][Full Text] [Related]
28. Fucoxanthin Protects against oxLDL-Induced Endothelial Damage via Activating the AMPK-Akt-CREB-PGC1α Pathway.
Ou HC; Chou WC; Chu PM; Hsieh PL; Hung CH; Tsai KL
Mol Nutr Food Res; 2019 May; 63(10):e1801353. PubMed ID: 30892786
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells.
Zeng J; Zhang Y; Ruan J; Yang Z; Wang C; Hong Z; Zuo Z
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5582-5589. PubMed ID: 29222657
[TBL] [Abstract][Full Text] [Related]
30. Fabrication of fucoxanthin/2-hydroxypropyl-β-cyclodextrin inclusion complex assisted by ultrasound procedure to enhance aqueous solubility, stability and antitumor effect of fucoxanthin.
Sun X; Zhu J; Liu C; Wang D; Wang CY
Ultrason Sonochem; 2022 Nov; 90():106215. PubMed ID: 36356498
[TBL] [Abstract][Full Text] [Related]
31. Dual-Enzyme Characteristics of Polyvinylpyrrolidone-Capped Iridium Nanoparticles and Their Cellular Protective Effect against H2O2-Induced Oxidative Damage.
Su H; Liu DD; Zhao M; Hu WL; Xue SS; Cao Q; Le XY; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8233-42. PubMed ID: 25826467
[TBL] [Abstract][Full Text] [Related]
32. Functional design of pH-responsive folate-targeted polymer-coated gold nanoparticles for drug delivery and in vivo therapy in breast cancer.
Mahalunkar S; Yadav AS; Gorain M; Pawar V; Braathen R; Weiss S; Bogen B; Gosavi SW; Kundu GC
Int J Nanomedicine; 2019; 14():8285-8302. PubMed ID: 31802866
[TBL] [Abstract][Full Text] [Related]
33. Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Zhao D; Kwon SH; Chun YS; Gu MY; Yang HO
Neurochem Res; 2017 Feb; 42(2):667-677. PubMed ID: 27933547
[TBL] [Abstract][Full Text] [Related]
34. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
35. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.
Liu C; Zhang S; McClements DJ; Wang D; Xu Y
J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074
[TBL] [Abstract][Full Text] [Related]
36. Degradation of Fucoxanthin to Elucidate the Relationship between the Fucoxanthin Molecular Structure and Its Antiproliferative Effect on Caco-2 Cells.
Komba S; Kotake-Nara E; Tsuzuki W
Mar Drugs; 2018 Aug; 16(8):. PubMed ID: 30082622
[TBL] [Abstract][Full Text] [Related]
37. Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone -hydroxyapatite nanocomposite encapsulated in double nanoemulsion.
Samadi A; Pourmadadi M; Yazdian F; Rashedi H; Navaei-Nigjeh M; Eufrasio-da-Silva T
Int J Biol Macromol; 2021 Jul; 182():11-25. PubMed ID: 33775763
[TBL] [Abstract][Full Text] [Related]
38. Preparation, Characterization and Antioxidant Activities of Kelp Phlorotannin Nanoparticles.
Bai Y; Sun Y; Gu Y; Zheng J; Yu C; Qi H
Molecules; 2020 Oct; 25(19):. PubMed ID: 33027947
[TBL] [Abstract][Full Text] [Related]
39. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
40. PVP-stabilized tungsten oxide nanoparticles: pH sensitive anti-cancer platform with high cytotoxicity.
Popov AL; Han B; Ermakov AM; Savintseva IV; Ermakova ON; Popova NR; Shcherbakov AB; Shekunova TO; Ivanova OS; Kozlov DA; Baranchikov AE; Ivanov VK
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110494. PubMed ID: 31924007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
